Navigation Links
Tacoma, Colorado Springs and Salt Lake City Have the Highest Percentage of HIV Patients in the U.S. Who Are Left Untreated
Date:9/16/2010

NASHVILLE, Tenn., Sept. 16 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, estimates that Tacoma, WA; Colorado Springs, CO and Salt Lake City, UT have the highest percentage of HIV patients who are left untreated. PatientFinder, HealthLeaders-InterStudy's analytics tool, finds that in these areas, 79 percent, 74 percent and 77 percent, respectively, of HIV positive individuals are not receiving any treatment and have prescription drug insurance.

"The high percentage of untreated patients who have prescription drug insurance in these markets is a great opportunity for pharmaceutical companies wishing to grow their patient base," says Andrew Laubscher, product director, PatientFinder. "Their focus should be on small- and mid-size markets to most effectively drive volume growth among patients who are not receiving treatment."

In addition, there are still an additional nine markets in the United States that have treatment rates below 20%, according to PatientFinder. While there are seven major U.S. markets with HIV treatment rates above 90%, there is a high variation in treatment rates across the U.S. that leave a significant amount of HIV patients untreated.

About PatientFinderPatientFinder covers each of the 50 U.S. states and U.S. metropolitan statistical areas (MSAs) and provides:

  • Disease-specific prevalence numbers for each U.S. state and MSA.
  • Examination of treatment rates for the disease population to create percent treated and percent untreated estimates by state and MSA.
  • Unique analysis of the untreated population examined through a filter of pharmacy benefit coverage. The end result is an estimate of how many patients are untreated but can afford therapy within each territory -- the true local measure of opportunity for pharmaceutical companies.

  • Indications covered in 2010 to include*:

  • Alzheimer's disease
  • Asthma
  • Bipolar depression
  • Chronic obstructive pulmonary disease
  • Crohn's disease
  • Dyslipidemia
  • Hepatitis C virus
  • HIV
  • Hypertension
  • Major depression
  • Multiple sclerosis
  • Parkinson's disease
  • Psoriasis
  • Rheumatoid arthritis
  • Schizophrenia
  • Type 2 diabetes (non-insulin)
  • Ulcerative colitis

  • *Indications subject to change.

    Why Pharmaceutical Companies Need This InformationWith the type of information included in PatientFinder, pharmaceutical organizations can identify the local markets that offer the greatest opportunity for their branded drug. Companies can identify markets that are underserved and determine if they should increase direct-to-consumer advertising, work with the local managed care organizations to increase awareness of the disease and benefits of their drug or align sales representatives to maximize market potential.

    About HealthLeaders-InterStudyHealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

    About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

    All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Erin O'Leary

    Elizabeth MarshallHealthLeaders-InterStudy

    Decision Resources, Inc.781-993-2641

    781-993-2563eoleary@dresources.com

    emarshall@dresources.com
    '/>"/>

    SOURCE HealthLeaders-InterStudy
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Tahoma, Colorado Springs and Salt Lake City Have the Highest Percentage of HIV Patients in the U.S. Who Are Left Untreated
    2. CO-REC Ready to Assist Colorado Health Care Providers in Implementing Electronic Health Record Systems and Achieving Meaningful Use
    3. Forensic Laboratories Selected for Colorado Companies to Watch Award
    4. Colorado-Based Spectranetics Corporation to Pay $5 Million to Resolve Allegations Relating to its Medical Devices
    5. Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings
    6. Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens
    7. American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver
    8. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
    9. Frost & Sullivan Recognizes Timoptic(R) (timolol maleate) as Best Brand Name Beta Blocker for Glaucoma: Timoptic Brand is Highest Rated in Survey of Ophthalmologists
    10. New Research from Best Practices, LLC Helps Medical Device Companies Earn the Highest Profit Possible During Their Products Patent Lifecycle
    11. Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
    (Date:2/11/2016)... -- - Cardiac Marker Diagnostic Testing ... Cancer Therapy. - European Point of Care Diagnostic ... - Key Diagnostic Testing Markets. - Molecular Diagnostics ... Testing. - Molecular Diagnostics in Infectious Disease Testing. ... Products World Markets. - Point of Care Diagnostic ...
    (Date:2/11/2016)... INC. (NasdaqCM: PDEX) today announced financial results for its fiscal ... filed its Quarterly Report on Form 10-Q for the second ... Commission today. --> --> ... --> Net sales for the three months ended ... million from $2.8 million for the three months ended December ...
    Breaking Medicine Technology:
    (Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of ... Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities ... before the big event. The invitation-only gifting suite, held this year at the W ...
    (Date:2/12/2016)... ... February 12, 2016 , ... ... (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into Cielo®, a ... offer real-time business intelligence (BI) to their small and medium business (SMB) clients. ...
    (Date:2/12/2016)... NC (PRWEB) , ... February 12, 2016 , ... AssureVest ... surrounding areas, is initiating a charity drive that will raise funds earmarked to purchase ... John C. Tayloe Elementary School. , “My school is in a low-income area and ...
    (Date:2/12/2016)... ... , ... Erlanger Agency has announced a new partnership in its ongoing community ... on the fight against breast cancer, fundraising for a local woman named Carmen, who ... Carmen is a loving single mother of two boys who also serves as caregiver ...
    (Date:2/12/2016)... ... February 12, 2016 , ... Miami Dental Specialists is excited to bring patients ... office. Beginning in January, Miami Dental Specialists will offer the non-metal implants as a ... office to be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge ...
    Breaking Medicine News(10 mins):